BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 14967311)

  • 1. Peripheral tolerance in transgenic mice expressing class I MHC L(d) only on cardiac cells.
    Margenthaler JA; Kataoka M; Flye MW
    Transpl Immunol; 2004 Jan; 12(2):133-41. PubMed ID: 14967311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of portal venous tolerant long-term MHC Class I L(d)-specific skin graft survival in transgenic 2CF1 mice.
    Margenthaler JA; Landeros K; Kataoka M; Flye MW
    Transpl Immunol; 2003; 11(1):23-9. PubMed ID: 12727472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of L(d+) transgenic mouse hearts.
    Margenthaler JA; Tu F; Otomo N; Shimizu Y; Yu S; Flye MW
    Surgery; 2001 Aug; 130(2):217-24. PubMed ID: 11490352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
    Margenthaler JA; Flye MW
    J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
    Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
    Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional oral tolerance in transgenic 2C mice.
    Margenthaler JA; Flye MW
    Surgery; 2005 Aug; 138(2):141-9. PubMed ID: 16153420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor-specific antigen transfusion-mediated skin-graft tolerance results from the peripheral deletion of donor-reactive CD8+ T cells.
    Margenthaler JA; Kataoka M; Flye MW
    Transplantation; 2003 Jun; 75(12):2119-27. PubMed ID: 12829922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in non-MHC alloantigens promote tissue rejection but fail to mediate allogeneic co-operation and autoimmunity in mice neonatally injected with semi-allogeneic F1 B cells.
    Ramos A; Merino R; Merino J
    Immunology; 1994 Jun; 82(2):287-93. PubMed ID: 7927500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Despite efficient intrathymic negative selection of host-reactive T cells, autoimmune disease may develop in porcine thymus-grafted athymic mice: evidence for failure of regulatory mechanisms suppressing autoimmunity.
    Zhao Y; Rodriguez-Barbosa JI; Shimizu A; Sachs DH; Sykes M
    Transplantation; 2003 Jun; 75(11):1832-40. PubMed ID: 12811242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific tolerance induction of allo-K(b)-skin grafts by FK506 in the CD8-depleted H-2(k) recipients required low amounts of K(b)-antigen.
    Chen BG; Liu Z; Wu Y
    Transpl Immunol; 2005 Oct; 15(1):9-16. PubMed ID: 16223668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early regulation of CD8 T cell alloreactivity by CD4+CD25- T cells in recipients of anti-CD154 antibody and allogeneic BMT is followed by rapid peripheral deletion of donor-reactive CD8+ T cells, precluding a role for sustained regulation.
    Fehr T; Takeuchi Y; Kurtz J; Wekerle T; Sykes M
    Eur J Immunol; 2005 Sep; 35(9):2679-90. PubMed ID: 16082727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance induction of allo-class I H-2 antigen-reactive Lyt-2+ helper T cells and prolonged survival of the corresponding class I H-2-disparate skin graft.
    Azuma T; Sato S; Kitagawa S; Hori S; Kokudo S; Hamaoka T; Fujiwara H
    J Immunol; 1989 Jul; 143(1):1-8. PubMed ID: 2525143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen recognition and allogeneic tumor rejection in CD8+ TCR transgenic/RAG(-/-) mice.
    Manning TC; Rund LA; Gruber MM; Fallarino F; Gajewski TF; Kranz DM
    J Immunol; 1997 Nov; 159(10):4665-75. PubMed ID: 9366389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-avidity CD8lo T cells induced by incomplete antigen stimulation in vivo regulate naive higher avidity CD8hi T cell responses to the same antigen.
    Maile R; Pop SM; Tisch R; Collins EJ; Cairns BA; Frelinger JA
    Eur J Immunol; 2006 Feb; 36(2):397-410. PubMed ID: 16402405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo-developed T cells have compromised response to existing alloantigens: using Ld-specific transgenic 2C T cells as tracers in a mouse heart transplantation model.
    Luo H; Chen H; Qi S; Loh D; Daloze P; Veillette A; Xu D; Wu J
    J Immunol; 1998 Jul; 161(1):73-82. PubMed ID: 9647209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vulnerability of allografts to rejection by MHC class II-restricted T-cell receptor transgenic mice.
    Lee MK; Huang X; Jarrett BP; Moore DJ; Desai NM; Moh Lian M; Markmann JW; Deng S; Frank A; Singer A; Velidedeoglu E; Caton AJ; Markmann AJ
    Transplantation; 2003 Apr; 75(8):1415-22. PubMed ID: 12717241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Split tolerance to the MHC class I molecule H-2Dd in animals transgenic for its soluble analog.
    Hunziker RD; Lynch F; Shevach EM; Margulies DH
    Hum Immunol; 1997 Feb; 52(2):82-94. PubMed ID: 9077557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel tool for B-cell tolerance research: characterization of mouse alloantibody development using a simple and reliable cellular ELISA technique.
    Fan X; Tyerman K; Ang A; Koo K; Parameswaran K; Tao K; Mai L; Lang H; West LJ
    Transplant Proc; 2005; 37(1):29-31. PubMed ID: 15808536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TCR transgenic CD8+ T cells activated in the presence of TGFbeta express FoxP3 and mediate linked suppression of primary immune responses and cardiac allograft rejection.
    Kapp JA; Honjo K; Kapp LM; Xu Xy; Cozier A; Bucy RP
    Int Immunol; 2006 Nov; 18(11):1549-62. PubMed ID: 16966495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alloreactive T cells that do not require TCR and CD8 coengagement are present in naive mice and contribute to graft rejection.
    Smith PA; Potter TA
    J Immunol; 1998 Jun; 160(11):5382-9. PubMed ID: 9605138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.